Yearly Publication Trends - adverse drug reactions

Year	Publication Count
2024	1795
2023	2759
2022	1918
2021	1473
2020	1117
2019	823
2018	594
2017	679
2016	712
2015	396
2014	348

Relevant Publications

Investigating the Benefit-Risk Profile of Drugs: From Spontaneous Reporting Systems to Real-World Data for Pharmacovigilance.

Issue Release: 2025

Brincidofovir inhibits polyomavirus infection .

Issue Release: 2024

A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.

Issue Release: 2024

Safety evaluation of bempedoic acid: A pharmacovigilance analysis using FDA adverse event reporting system data.

Issue Release: 2024

Efficacy and safety of galacto-oligosaccharide in the treatment of functional constipation: randomized clinical trial.

Issue Release: 2024

SAFE PENICILLIN ALLERGY DE-LABELLING IN PRIMARY CARE, A SYSTEMATIC REVIEW AND META-ANALYSIS.

Issue Release: 2024

Drug-induced photosensitivity associated with anticancer therapies.

Issue Release: 2024

Accurate prediction of drug combination risk levels based on relational graph convolutional network and multi-head attention.

Issue Release: 2024

Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review.

Issue Release: 2024

Remimazolam anaphylaxis in a patient not allergic to brotizolam: a case report and literature review.

Issue Release: 2024

Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies.

Issue Release: 2024

Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection.

Issue Release: 2024

Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study.

Issue Release: 2024

The effect of Bushenhuoxue nutritional decoction in the treatment of overweight patients with polycystic ovarian syndrome.

Issue Release: 2024

Pharmacotherapy and cardiovascular challenges: a case report of olverembatinib-induced myocardial infarction with non-obstructive coronary arteries.

Issue Release: 2024

Safety and Efficacy of Paxlovid in Pediatric Intensive Care Unit Patients with COVID-19.

Issue Release: 2024

Moderate and serious adverse reactions to antimicrobials among hospitalized children: A systematic review.

Issue Release: 2024

Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction.

Issue Release: 2024

Integrating Chinese medicine into mainstream cancer therapies: a promising future.

Issue Release: 2024

Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus.

Issue Release: 2024

What Role Does Cellular Stress Play in Disease?

What Are the Challenges in Managing Chronic Conditions?

How are ADEs Detected and Reported?

Why is Medication Management Important?

What is Cellular Stress?

What is Generic Competition?

How Does Cellular Stress Impact Drug Development?

How Do Pharmacists Contribute to Patient Care?

How Can Technology Aid in Patient Education?

What Challenges Do Pharmacists Face?

Partnered Content Networks

Relevant Topics